1. South Korea Stocks

  2. •

    Health technology

  3. •

    Medical specialties
COXEM Co., Ltd.

COXEM Co., Ltd.

KKRX:360350
10,850.00
KRW
-40.00
(-0.37%)
-213.82EPS
35.50BMarket Cap
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
2,967.74
1,900.18
1,933.88
2,540.67
2,747.44
2,635.33
2,485.35
2,353.46
Basic EPS, GAAP
268
74
101
348
337
178.86
-121
-173.17
Free Cash Flow per Basic Share
560.12
-126.4
102.28
374.32
-72.59
-173.8
-167.5
-335.39
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
1,292.6
1,543.88
1,756.67
2,124.29
2,529.97
4,059.81
3,596.71
2,981.04
Tangible Book Value per Share
1,289.15
1,536.96
1,750.54
2,109.97
2,498.22
3,992.45
3,513.57
2,890.31
Basic Weighted Avg Shares
3
5
5
5
5
6
5
5
Sales/Revenue/Turnover
7,722
8,654
9,490
12,525
13,729
14,730
13,390
12,572
Operating Margin (%)
2.99
2.96
1.65
14.24
10.99
-1.57
-11.35
-17.53
Depreciation Expense
223
257
296
360
365
477
555
585
Net Income, GAAP
697
337
496
1,716
1,684
1,000
-652
-925
Effective Tax Rate (%)
- -
- -
- -
3.4
0.27
- -
- -
- -
Profit Margin (%)
9.03
3.89
5.22
13.7
12.27
6.79
-4.87
-7.36
Working Capital
5,605
6,720
7,523
9,574
10,767
20,674
14,106
10,440
LT Debt
31
62
108
510
57
514
47
73
Total Equity
6,520
7,787
8,861
10,715
12,761
23,108
18,357
15,032
Return on Invested Capital (%)
- -
- -
- -
18.28
12.76
- -
- -
- -
Return on Capital (%)
- -
- -
- -
16.76
13.68
- -
- -
- -
Return on Common Equity (%)
- -
4.71
5.95
17.53
14.35
5.57
-3.13
-5.54

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
1,610
2,605
2,571
LT Borrowings
- -
- -
- -
LT Finance Leases
47
84
73
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
5
5
5
Market Capitalization
35,401
82,844
35,505

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
17,798
16,044
15,577
Cash, Cash Equivalents & STI
8,400
8,090
6,616
Accounts Receivable, Net
2,471
1,643
- -
Inventories
6,374
5,849
6,448
Total Current Liabilities
3,692
3,866
5,137
Payables & Accruals
- -
- -
- -
ST Debt
1,610
2,605
2,571
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
22.87%
-20.56%
Free Cash Flow
- -
24.3%
-7.1%
Net Income, GAAP
- -
17.11%
-165.21%
Sales/Revenue/Turnover
- -
9.89%
-9.1%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,665
3,151
2,624
6,290
14,730
2025
3,145
2,920
2,512
4,814
13,390
2026
2,525
2,722
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-27
-57
-52
266.34
178.86
2025
-36
-154
-87.64
160.31
-121
2026
-146.07
-92
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Jun-Hee Lee
Full Time Employees
63
Sector
Health technology
Industry
Medical specialties
Address
Migun Techno World 1-cha, Daejeon DE South Korea 34025
IPO Date
Feb 23, 2024
Website
coxem.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Coxem Co., Ltd. COXEM Co., Ltd. (KOSDAQ: 360350) manufactures and sells scanning electron microscopes (SEMs) and related peripheral equipment for nanoscale micro-material analysis in the nanotechnology sector. The company offers a range of core products including tabletop SEMs such as the EM-30 series (EM-30N, EM-30AXN, EM-30LE, EM-30Plus, and EM-30AX), full-sized SEMs like the CX-200 series (CX-200K, CX-200Plus, CX-200TM, and CX-200TA), ion beam polishers (CP-8000+ and CP-SEM), ion sputter coaters (SPT-20), and optional accessories such as STEM detectors, EDS and BSE detectors, compact EBSD detectors, cool stages, air protection transfer modules, sample holders, filaments, and ion coater targets; these solutions serve applications in life sciences, material sciences, ion milling, and advanced imaging with features like high-resolution SE/BSE imaging, motorized stages, and CeB6 filament options. Founded in 2007 and headquartered in Daejeon, South Korea, with a second laboratory in Pangyo, Coxem operates globally through distributors in regions including Europe, Asia, and the Middle East, targeting research institutions, industrial labs, and semiconductor industries. In recent developments, the company listed on the KOSDAQ exchange in February 2022 following approval of its preliminary listing examination, relocated its second lab to Pangyo in 2021, launched the CX-200Plus full-sized SEM and CP-8000 ion beam polisher in 2018, earned certifications including New Excellent Technology for CP-SEM in May 2023 and high-tech enterprise status, achieved accumulated sales of over 850 devices by 2022, received the Prime Minister's Award for Industrial Technology at Nano Korea 2023, and continues to expand via international exhibitions such as M&M 2023, JASIS 2023, and IMC20.